Atossa Therapeutics, Inc. (ATOS) by event type
ATOS moves most on price-target raises — a median of -0.17% at 30 minutes across 10 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ATOS overview →
How ATOS reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Rating reiterations 966 of 3,522 | 40 | +0.08% | 50% | -1.31% |
| Price-target raises 1,520 of 1,790 | 10 | -0.17% | 40% | -0.91% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how ATOS usually reacts — get an email when it moves on news →Every name measured for these event types: Rating reiterations → · Price-target raises → · ATOS overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EKIMAS CORPORATION (ASNB) | 223 | 0.00% | 45% |
| OASMIA PHARMACEUTICALS AB AMERICAN DEPOSITARY SHARE (OASM) | 223 | 0.00% | 35% |
| FibroGen, Inc (FGEN) | 220 | -0.50% | 45% |
| INNOVATE BIOPHARMACEUTICALS (INNT) | 220 | -0.77% | 38% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.